NCT05198960 2025-02-04
AVAJAK
University Hospital, Brest
Phase 3 Recruiting
Clinical Trials
5 trialsNCT03003325 2024-09-19
Low-PV
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase 2 Completed
NCT04243122 2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2 Completed
NCT01259817 2017-01-11
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00940784 2014-11-26
ISCLAP
Icahn School of Medicine at Mount Sinai
Phase 2 Withdrawn